Cancer Research Targets  Frontiers in Basic Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hibino, S.
Right arrow Articles by Kleinman, H. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hibino, S.
Right arrow Articles by Kleinman, H. K.
[Cancer Research 64, 4810-4816, July 15, 2004]
© 2004 American Association for Cancer Research


Regular Articles

Identification of an Active Site on the Laminin {alpha}5 Chain Globular Domain That Binds to CD44 and Inhibits Malignancy

Suguru Hibino1,2, Masahiko Shibuya3, Jean A. Engbring1, Mayumi Mochizuki4, Motoyoshi Nomizu4 and Hynda K. Kleinman1

1 Craniofacial Developmental Biology and Regeneration Branch, National Institute of Dental and Craniofacial Research, NIH, Bethesda, Maryland; 2 Fourth Department of Internal Medicine, Nippon Medical School, Tokyo, Japan; 3 Respiratory Division of Internal Medicine, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan; and 4 Graduate School of Environmental Earth Science, Hokkaido University, Sapporo, Japan

The laminin {alpha}5 chain is a component of laminin-10 ({alpha}5ß1{gamma}1) and -11 ({alpha}5ß2{gamma}1). In this study, we have screened 113 overlapping synthetic peptides from the laminin {alpha}5 globular domain (G-domain) for cell attachment activity with B16-F10 cells using peptide-coated dishes. Eleven attachment-active peptides were identified. In vivo experimental B16-F10 pulmonary metastasis and primary tumor growth assays found that 4 of the 11 peptides inhibited tumor metastasis and growth and increased apoptosis. These four peptides also blocked tumor cell migration, invasion, and angiogenesis. Two of the peptides were highly homologous and showed significant similarity to sequences in collagens. We sought to identify the B16-F10 cell surface receptors for each of the four active peptides using peptide affinity chromatography. Only one peptide recognized a cell surface protein. Peptide A5G27 (RLVSYNGIIFFLK, residues 2892–2904) bound a diffuse Mr ~120,000–180,000 band that eluted with 2 M NaCl. Glycosidase digestion of the 2 M eluate yielded protein bands of Mr 90,000 and 60,000 that reacted in Western blot analysis with antibodies to CD44. Immunoprecipitation of the A5G27-bound membrane proteins with various cell surface proteoglycan antibodies confirmed CD44 as the surface receptor for A5G27. Finally, attachment assays to A5G27 in the presence of soluble glycosaminoglycans (GAGs) identified the GAGs of CD44 as the binding sites for A5G27. Our results suggest that A5G27 binds to the CD44 receptor of B16-F10 melanoma cells via the GAGs on CD44 and, thus, inhibits tumor cell migration, invasion, and angiogenesis in a dominant-negative manner.




This article has been cited by other articles:


Home page
Cancer Res.Home page
H. L. Goel, L. Moro, J. E. Murphy-Ullrich, C.-C. Hsieh, C.-L. Wu, Z. Jiang, and L. R. Languino
{beta}1 Integrin Cytoplasmic Variants Differentially Regulate Expression of the Antiangiogenic Extracellular Matrix Protein Thrombospondin 1
Cancer Res., July 1, 2009; 69(13): 5374 - 5382.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Akalu, J. M. Roth, M. Caunt, D. Policarpio, L. Liebes, and P. C. Brooks
Inhibition of Angiogenesis and Tumor Metastasis by Targeting a Matrix Immobilized Cryptic Extracellular Matrix Epitope in Laminin
Cancer Res., May 1, 2007; 67(9): 4353 - 4363.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
T. C. Sroka, M. E. Pennington, and A. E. Cress
Synthetic D-amino acid peptide inhibits tumor cell motility on laminin-5
Carcinogenesis, September 1, 2006; 27(9): 1748 - 1757.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Hibino, M. Shibuya, M. P. Hoffman, J. A. Engbring, R. Hossain, M. Mochizuki, S. Kudoh, M. Nomizu, and H. K. Kleinman
Laminin {alpha}5 Chain Metastasis- and Angiogenesis-Inhibiting Peptide Blocks Fibroblast Growth Factor 2 Activity by Binding to the Heparan Sulfate Chains of CD44
Cancer Res., November 15, 2005; 65(22): 10494 - 10501.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.